BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27225804)

  • 1. Clinical and prognostic utility of cardiovascular magnetic resonance imaging in myeloma patients with suspected cardiac amyloidosis.
    Bhatti S; Watts E; Syed F; Vallurupalli S; Pandey T; Jambekar K; Mazur W; Hakeem A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):970-7. PubMed ID: 27225804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis.
    Austin BA; Tang WH; Rodriguez ER; Tan C; Flamm SD; Taylor DO; Starling RC; Desai MY
    JACC Cardiovasc Imaging; 2009 Dec; 2(12):1369-77. PubMed ID: 20083070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis.
    Wan K; Sun J; Han Y; Liu H; Yang D; Li W; Wang J; Cheng W; Zhang Q; Zeng Z; Chen Y
    Circ J; 2018 Feb; 82(3):739-746. PubMed ID: 29093431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.
    Pedrotti P; Vittori C; Facchetti R; Pedretti S; Dellegrottaglie S; Milazzo A; Frigerio M; Cipriani M; Giannattasio C; Roghi A; Rimoldi O
    Eur Heart J Cardiovasc Imaging; 2017 Feb; 18(2):130-137. PubMed ID: 27625368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Combined Incremental Prognostic Value of LVEF, Late Gadolinium Enhancement, and Global Circumferential Strain Assessed by CMR.
    Mordi I; Bezerra H; Carrick D; Tzemos N
    JACC Cardiovasc Imaging; 2015 May; 8(5):540-549. PubMed ID: 25890580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    Raina S; Lensing SY; Nairooz RS; Pothineni NV; Hakeem A; Bhatti S; Pandey T
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1267-1277. PubMed ID: 27568115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis.
    Wan K; Sun J; Han Y; Luo Y; Liu H; Yang D; Cheng W; Zhang Q; Zeng Z; Chen Y
    Heart Vessels; 2018 Feb; 33(2):170-179. PubMed ID: 28840397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the prognostic relevance of myocardial ischaemia and scar by cardiac magnetic resonance in patients with and without diabetes mellitus.
    Giusca S; Kelle S; Nagel E; Buss SJ; Voss A; Puntmann V; Fleck E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):812-20. PubMed ID: 26358695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences in prognostic value of cardiac valve plane displacement in systemic light-chain amyloidosis.
    Ochs MM; Fritz T; Arenja N; Riffel J; Andre F; Mereles D; Siepen FAD; Hegenbart U; Schönland S; Katus HA; Friedrich MGW; Buss SJ
    J Cardiovasc Magn Reson; 2017 Nov; 19(1):87. PubMed ID: 29121956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis.
    Maceira AM; Prasad SK; Hawkins PN; Roughton M; Pennell DJ
    J Cardiovasc Magn Reson; 2008 Nov; 10(1):54. PubMed ID: 19032744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhanced cardiac MR derived radiomics approach for predicting all-cause mortality in cardiac amyloidosis: a multicenter study.
    Zhou XY; Tang CX; Guo YK; Chen WC; Guo JZ; Ren GS; Li X; Li JH; Lu GM; Huang XH; Wang YN; Zhang LJ; Yang GF
    Eur Radiol; 2024 Jan; 34(1):402-410. PubMed ID: 37552255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
    Chatzantonis G; Bietenbeck M; Elsanhoury A; Tschöpe C; Pieske B; Tauscher G; Vietheer J; Shomanova Z; Mahrholdt H; Rolf A; Kelle S; Yilmaz A
    Clin Res Cardiol; 2021 Apr; 110(4):555-568. PubMed ID: 33170349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis assessment of cardiac involvement in systemic AL amyloidosis by magnetic resonance imaging.
    Mekinian A; Lions C; Leleu X; Duhamel A; Lamblin N; Coiteux V; De Groote P; Hatron PY; Facon T; Beregi JP; Hachulla E; Launay D;
    Am J Med; 2010 Sep; 123(9):864-8. PubMed ID: 20800158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.
    Cavalcante JL; Rijal S; Abdelkarim I; Althouse AD; Sharbaugh MS; Fridman Y; Soman P; Forman DE; Schindler JT; Gleason TG; Lee JS; Schelbert EB
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):98. PubMed ID: 29212513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis.
    Gräni C; Eichhorn C; Bière L; Murthy VL; Agarwal V; Kaneko K; Cuddy S; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY
    J Am Coll Cardiol; 2017 Oct; 70(16):1964-1976. PubMed ID: 29025553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
    Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
    Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.